$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study
07:27am, Monday, 09'th Mar 2026
U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic skin disease met the main goal in a mid-stage study.
Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
06:45am, Monday, 09'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermati
111,750 Shares in Pfizer Inc. $PFE Bought by Black Swift Group LLC
05:02am, Sunday, 08'th Mar 2026
Black Swift Group LLC acquired a new stake in shares of Pfizer Inc. (NYSE: PFE) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commis
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)
08:15am, Saturday, 07'th Mar 2026
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
First Trust Advisors LP Increases Position in Pfizer Inc. $PFE
04:55am, Saturday, 07'th Mar 2026
First Trust Advisors LP raised its stake in shares of Pfizer Inc. (NYSE: PFE) by 4.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Th
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 06'th Mar 2026
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies
06:05am, Friday, 06'th Mar 2026
U.S. considers global AI chip export restrictions, impacting Nvidia and AMD as shares fall on regulatory risk. A 30-day U.S. waiver allows India to purchase stranded Russian crude, aiming to stabilize
China approves Pfizer GLP-1 drug for weight management
12:40am, Friday, 06'th Mar 2026
China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a market
Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund
04:48pm, Thursday, 05'th Mar 2026
A federal judge on Thursday awarded Pfizer $29 million to resolve a dispute with the U.S. Securities and Exchange Commission stemming from the regulator's 2013 insider trading settlement with bi
Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound?
12:35pm, Thursday, 05'th Mar 2026
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?
Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?
09:46am, Thursday, 05'th Mar 2026
PFE faces falling COVID sales, looming patent cliffs and IRA pressure. It is betting on cost cuts, new launches and pipeline rebuilds to revive growth.
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today
01:47pm, Wednesday, 04'th Mar 2026
Teva Pharmaceutical is a bit of a turnaround story, as the company continues a major business overhaul. This competitor, with a huge 6.3% yield, has hit a few setbacks, but it is still just business a
Seven S&P500 Ideal 'Safer' March Dividend Dogs
11:31am, Wednesday, 04'th Mar 2026
Seven S&P 500 dividend 'Dogs'—including VICI, VZ, BEN, F, HST, T, and KEY—offer high yields supported by sufficient free cash flow, making them attractive buys. Analyst forecasts project 14.2% to
Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
09:09am, Wednesday, 04'th Mar 2026
Pfizer's portfolio renewal is in progress, with new launches and acquisitions driving +14.6% YoY growth in new product revenues, though legacy drug expiries may pressure intermediate-term sales. These
NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals
08:55am, Wednesday, 04'th Mar 2026
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the N
Sign In
Buy PFE